Chemical Genomics and Proteomics

E-bok

Engelska, 2013

1 320 kr

Läs direkt i Bokus Reader – eller ladda ned till din enhet

Beskrivning

Since the publication of the pioneering first edition of Chemical Genomics and Proteomics more than seven years ago, the area of chemical genomics has rapidly expanded and diversified to numerous novel methods and subdisciplines, such as chemical glycomics and lipidomics. This second edition has been updated to uniquely reflect this interdisciplinary feature as well as the remarkable developments that have occurred. The new edition also covers innovative applications from cell biology to drug discovery to, more recently, clinical diagnostics and medical practice.

Produktinformation

Utgivningsdatum:2013-01-11
Språk:Engelska
Filformat:EPUB
Kopieringsskydd:LCP
ISBN:9781040067925
Förlag:Taylor & Francis Ltd
Upplaga:2

Utforska kategorier

Kemi inom Naturvetenskap och teknik
Biologi inom Naturvetenskap och teknik
Biokemisk teknik inom Naturvetenskap och teknik

Mer om författaren

Ferenc Darvas, András Guttman, György Dormán

Recensioner i media

Praise for the First Edition"I thoroughly enjoyed this book and have already had to retrieve it from my PhD students who are anxious to read it ...make sure your library has a copy!"—Journal of Chemical Technology and Biotechnology, Vol. 80, Issue 8, August 2005"[This book] is the first book dedicated solely to chemical genomics. It presents the most important research and developments in chemical genomics … The plentiful tables and figures are well-designed and effectively support the content. … highly recommended for academic and special libraries with relevant programs, and for research scientists in the field."—E-Streams

Innehållsförteckning

Utilizing small molecules in chemical genomics: Toward high-throughput approaches. Development and application of novel analytical methods in lipidomics. From chemical genomics to chemical proteomics: The power of microarray technology. Genomic and proteomic biomarkers in the drug R&D process. Quo vadis biomedical sciences in the omics era: Toward computational biology and medicine. Novel chemogenomic approaches to drug design.